These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23743657)

  • 41. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
    Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W
    Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid leakage from PEGylated liposomes triggered by bubbles.
    Fujie T; Yoshimoto M
    Soft Matter; 2019 Dec; 15(46):9537-9546. PubMed ID: 31712795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
    Arouri A; Mouritsen OG
    Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
    Xu Y; Meng H
    Artif Cells Nanomed Biotechnol; 2016; 44(1):350-5. PubMed ID: 25162671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
    Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic and structural aspects of PEGylated liposomes monitored by NMR.
    Leal C; Rögnvaldsson S; Fossheim S; Nilssen EA; Topgaard D
    J Colloid Interface Sci; 2008 Sep; 325(2):485-93. PubMed ID: 18589432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
    Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
    Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane properties of cationic liposomes composed of dipalmitoylphosphatidylcholine and dipalmityldimethylammonium bromide.
    Yokoyama S; Inagaki A; Imura T; Ohkubo T; Tsubaki N; Sakai H; Abe M
    Colloids Surf B Biointerfaces; 2005 Sep; 44(4):204-10. PubMed ID: 16087320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
    Gabizon A; Martin F
    Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.
    Li L; ten Hagen TL; Schipper D; Wijnberg TM; van Rhoon GC; Eggermont AM; Lindner LH; Koning GA
    J Control Release; 2010 Apr; 143(2):274-9. PubMed ID: 20074595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
    Zhang J; Chen Y; Li X; Liang X; Luo X
    Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maleimide-Decorated PEGylated Mucoadhesive Liposomes for Ocular Drug Delivery.
    Moiseev RV; Kaldybekov DB; Filippov SK; Radulescu A; Khutoryanskiy VV
    Langmuir; 2022 Nov; 38(45):13870-13879. PubMed ID: 36327096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a liposome formulation for D-cycloserine local delivery.
    Musumeci T; Ventura CA; Giannone I; Pignatello R; Puglisi G
    J Liposome Res; 2008; 18(3):211-24. PubMed ID: 18726817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
    Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
    Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes.
    Edwards K; Johnsson M; Karlsson G; Silvander M
    Biophys J; 1997 Jul; 73(1):258-66. PubMed ID: 9199790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation.
    Begum MY; M Osmani RA; Alqahtani A; Ghazwani M; Hani U; Ather H; Atiya A; Rahamathulla M; Siddiqua A
    PLoS One; 2022; 17(4):e0264518. PubMed ID: 35472207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The encapsulation and release of guanosine from PEGylated liposomes.
    Er Y; Barnes TJ; Fornasiero D; Prestidge CA
    J Liposome Res; 2009; 19(1):29-36. PubMed ID: 19515005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.
    Biswas S; Dodwadkar NS; Deshpande PP; Parab S; Torchilin VP
    Eur J Pharm Biopharm; 2013 Aug; 84(3):517-25. PubMed ID: 23333899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.